2024
EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer
Ermer T, Kim S, Goldberg S, Zolfaghari E, Blasberg J, Boffa D, Herbst R, Politi K, Schalper K, Dacic S, Woodard G. EP.07C.10 Real-World Outcomes of Patients Treated with Neoadjuvant Immunotherapy for Resectable Non-Small Cell Lung Cancer. Journal Of Thoracic Oncology 2024, 19: s543-s544. DOI: 10.1016/j.jtho.2024.09.1007.Peer-Reviewed Original Research
2021
Breast metastases from primary lung cancer: a retrospective case series on clinical, ultrasonographic, and immunohistochemical features
Wang B, Jiang Y, Li SY, Niu RL, Blasberg JD, Kaifi JT, Liu G, Wang ZL. Breast metastases from primary lung cancer: a retrospective case series on clinical, ultrasonographic, and immunohistochemical features. Translational Lung Cancer Research 2021, 0: 0-0. PMID: 34430360, PMCID: PMC8350075, DOI: 10.21037/tlcr-21-542.Peer-Reviewed Original ResearchPrimary lung cancerRetrospective case seriesBreast metastasisLung cancerCase seriesImmunohistochemical featuresCytokeratin 7Breast nodulesPrimary breast malignancyThyroid transcription factor-1Lung cancer metastasisAxillary lymphadenopathyClinical featuresLung metastasesImmunohistochemical findingsTranscription factor 1Ultrasonographic featuresBreast malignancyUltrasound featuresUltrasonographic characteristicsImmunohistochemical dataClinical practiceMetastasisNapsin A.Cancer
2019
A new approach to predicting risk for N2 disease in non-small cell lung cancer
Decker RH, Blasberg JD. A new approach to predicting risk for N2 disease in non-small cell lung cancer. Journal Of Thoracic Disease 2019, 1: s1973-s1975. PMID: 31632801, PMCID: PMC6783735, DOI: 10.21037/jtd.2019.07.61.Peer-Reviewed Original ResearchQuality Versus Quantity
Chiu AS, Arnold BN, Hoag JR, Herrin J, Kim CH, Salazar MC, Monsalve AF, Jean RA, Blasberg JD, Detterbeck FC, Gross CP, Boffa DJ. Quality Versus Quantity. Annals Of Surgery 2019, Publish Ahead of Print: &na;. PMID: 29697446, DOI: 10.1097/sla.0000000000002762.Peer-Reviewed Original ResearchConceptsComplex cancer surgeryCancer surgerySafe hospitalComplex oncologic surgeryPotential mortality reductionNational Cancer DatabaseHigh-volume hospitalsHospital quality measuresSurgical mortalityPrimary cancerHospital rating systemsOncologic surgeryCancer DatabaseMortality reductionSurgical volumeHospital safetyPatient realignmentPatientsHospitalSurgeryMeaningful reductionPublic reportingMortalityRSMRCancer
2018
MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3)
Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, Nicholas A, Schulze K, Phan S, Gandhi M, Carbone D. MA04.09 Neoadjuvant Atezolizumab in Resectable Non-Small Cell Lung Cancer (NSCLC): Updated Results from a Multicenter Study (LCMC3). Journal Of Thoracic Oncology 2018, 13: s369. DOI: 10.1016/j.jtho.2018.08.346.Peer-Reviewed Original ResearchNeoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3).
Rusch V, Chaft J, Johnson B, Wistuba I, Kris M, Lee J, Bunn P, Kwiatkowski D, Reckamp K, Finley D, Haura E, Waqar S, Doebele R, Garon E, Blasberg J, Nicholas A, Schulze K, Phan S, Gandhi M, Carbone D. Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Initial results from a multicenter study (LCMC3). Journal Of Clinical Oncology 2018, 36: 8541-8541. DOI: 10.1200/jco.2018.36.15_suppl.8541.Peer-Reviewed Original ResearchProgress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017
Donington JS, Kim YT, Tong B, Moreira AL, Bessich J, Weiss KD, Colson YL, Wigle D, Osarogiagbon RU, Zweig J, Wakelee H, Blasberg J, Daly M, Backhus L, Van Schil P. Progress in the Management of Early-Stage Non–Small Cell Lung Cancer in 2017. Journal Of Thoracic Oncology 2018, 13: 767-778. PMID: 29654928, DOI: 10.1016/j.jtho.2018.04.002.Peer-Reviewed Original ResearchConceptsCell lung cancerLung cancerEarly-stage non-small cell lung cancerNon-small cell lung cancerEarly-stage lung cancer patientsSmall cell lung cancerEarly-Stage NonEarly-stage diseaseLung cancer patientsQuality of lifeAdvanced diseaseAdjuvant therapyCancer patientsThoracic oncologyFocused updateSurgical techniqueTailor treatmentCancerDiseaseLandscape of careCareMultiple areasAnnual updateUnpublished dataNovel unpublished dataSpontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database
Arnold BN, Chiu AS, Hoag JR, Kim CH, Salazar MC, Blasberg JD, Boffa DJ. Spontaneous regionalization of esophageal cancer surgery: an analysis of the National Cancer Database. Journal Of Thoracic Disease 2018, 10: 1721-1731. PMID: 29707326, PMCID: PMC5906219, DOI: 10.21037/jtd.2018.02.12.Peer-Reviewed Original ResearchLow-volume hospitalsNational Cancer DatabaseProportion of patientsHigh-volume hospitalsEsophageal cancer surgeryEsophagectomy patientsHigh-risk attributesCancer surgeryEra 2Cancer DatabaseHigh-risk patientsPrimary outcomeEsophageal cancerEra 1Retrospective analysisMortality ratePatientsEsophagectomyHospitalSurgeryFurther studiesCancerCliniciansMortalityProportion
2017
Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians
Arnold BN, Thomas DC, Rosen JE, Salazar MC, Detterbeck FC, Blasberg JD, Boffa DJ, Kim AW. Effectiveness of local therapy for stage I non–small-cell lung cancer in nonagenarians. Surgery 2017, 162: 640-651. PMID: 28697883, DOI: 10.1016/j.surg.2017.04.025.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overCarcinoma, Non-Small-Cell LungConfidence IntervalsDatabases, FactualDisease-Free SurvivalFemaleGeriatric AssessmentHumansKaplan-Meier EstimateLogistic ModelsLung NeoplasmsMaleMultivariate AnalysisNeoplasm InvasivenessNeoplasm StagingOdds RatioPneumonectomyProportional Hazards ModelsRadiotherapyRegistriesRisk AssessmentSecondary PreventionSurvival AnalysisConceptsCell lung cancerLocal therapyLung cancerStage IRelative survivalStereotactic body radiation therapyNational Cancer DatabaseBetter overall survivalBody radiation therapyOlder patientsOverall survivalPatient ageYounger patientsOverall mortalityPrimary outcomeCancer DatabaseTreatment outcomesTreatment decisionsRadiation therapyPatientsTherapyCancerNonagenariansTreatmentSurvival
2016
Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement
Gao S, Corso C, Wang E, Blasberg J, Boffa D, Detterbeck F, Kim A. Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement. International Journal Of Radiation Oncology • Biology • Physics 2016, 96: e470. DOI: 10.1016/j.ijrobp.2016.06.1811.Peer-Reviewed Original ResearchLung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base
Arnold BN, Thomas DC, Rosen JE, Salazar MC, Blasberg JD, Boffa DJ, Detterbeck FC, Kim AW. Lung Cancer in the Very Young: Treatment and Survival in the National Cancer Data Base. Journal Of Thoracic Oncology 2016, 11: 1121-1131. PMID: 27103511, DOI: 10.1016/j.jtho.2016.03.023.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerNational Cancer Data BaseYounger patientsOlder patientsLung cancerRelative survivalStage IAdvanced stage non-small cell lung cancerCell lung cancerYears of ageAggressive therapyAggressive treatmentOverall survivalPatient demographicsPrimary outcomeTreatment patternsTumor characteristicsNSCLC casesPatientsStage IIIDetailed stagingSurvival informationOlder groupDistinct subsetsCancer
2012
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population
Joseph S, Harrington R, Walter D, Goldberg JD, Li X, Beck A, Litton T, Hirsch N, Blasberg J, Slomiany M, Rom W, Pass H, Donington J. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomarkers 2012, 12: 177-184. PMID: 23568008, PMCID: PMC3746829, DOI: 10.3233/cbm-130306.Peer-Reviewed Original ResearchConceptsIncident cancerPlasma osteopontinNon-small cell lung cancer careLung cancer careCase-control studySerial plasmaNSCLC patientsCT screeningSurveillance intervalsCancer careLung cancerPlasma levelsWilcoxon Signed Rank TestDisease statusCancerSigned Rank TestBenign nodulesSecreted phosphoproteinCTRank testOsteopontinEarly evidenceNSCLCPatientsNSCLCs
2011
Management of Early Stage Non–Small Cell Lung Cancer in High-Risk Patients
Donington JS, Blasberg JD. Management of Early Stage Non–Small Cell Lung Cancer in High-Risk Patients. Thoracic Surgery Clinics 2011, 22: 55-65. PMID: 22108689, DOI: 10.1016/j.thorsurg.2011.08.018.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerEarly-stage non-small cell lung cancerHigh-risk patientsCell lung cancerLung cancerStage I non-small cell lung cancerStage non-small cell lung cancerPeri-procedural morbidityOperable lung cancerType of resectionRefinement of indicationsAnatomic resectionMediastinal lymphSublobar resectionOncologic efficacyTreatment optionsPreferred treatmentResectionPatientsCancerTreatmentLobectomyLymphMorbidityMortality